Navigation Links
IDM Pharma Reports 2007 Financial Results
Date:3/20/2008

A for L-MTP-PE submitted by the Company may not provide adequate support for regulatory approval of L-MTP-PE in the United States within the timeframe expected by the Company, if at all, whether the Company will be able to manufacture and commercialize L-MTP-PE even if it is approved by regulatory authorities, and whether the cash resources of the Company will be sufficient to fund operations as planned. These and other risks affecting the Company and its drug development programs, intellectual property rights, personnel and business are more fully discussed in the Company's Quarterly Report on Form 10-Q filed with the SEC for the quarter ended September 30, 2007 and other periodic reports filed with the SEC. The Company expressly disclaims any intent or obligation to update these forward-looking statements, except as required by law.

IDM PHARMA, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share amounts)

(unaudited)

Twelve Months

Quarter Ended December 31, Ended December 31,

2007 2006 2007 2006

Revenues:

Related party

revenue $5,252,000 $2,919,000 $14,246,000 $11,147,000

Research grants and

contract revenue - 28,000 55,000 96,000

License fees,

milestones and

other revenues 299,000 11,000 329,000 43,000

Total revenues 5,551,000 2,958,000 14,630,000 11,286,000

Costs and expenses:

Research and

development 4,796,000 5,297,000 21,828,000 22,329,000

Impairment of

patents and

licenses 416,000 95,000 511,000 592,000


'/>"/>
SOURCE IDM Pharma, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?
2. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
3. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
4. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
5. The Pharma & Life Sciences Best Practice Database: an Industry Resource for Successful Techniques and Performance Benchmarks for Reaching the Top
6. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
8. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
9. AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
11. Innocoll Agrees the Sale of its CollaRx(R) GENTAMICIN SURGICAL IMPLANT and European Sales and Marketing Infrastructure to EUSA Pharma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... A new type of festival is emerging ... on Tap at the Science Museum of Virginia not only ... science hops for a bold, new flavor. , The 21+ ... up the science behind these frothy beverages. Guests uncover the ... at the ingredients that go into beer with Original Gravity ...
(Date:4/27/2015)... Calif. (PRWEB) April 27, 2015 ... surrounding the molecular basis of an inherited disorder ... but now also arises in other populations of ... Through a series of elegant experiments, the researchers ... type of leukodystrophy that is an incurable and ...
(Date:4/27/2015)... (PRWEB) April 27, 2015 Diamond reflective ... unneeded risk of damaging hot spots. , Gorilla Grow ... because of their sturdy structure and strong material that ... was design to effectively distribute lumens and eliminates hot ... most benefit from grow lights and produces the highest ...
(Date:4/27/2015)... (PRWEB) April 27, 2015 Thanks to ... Health, researchers from a half-dozen institutions, including American University, ... epidemiological, basic and social and behavioral research aimed at ... D.C. residents are living with HIV or AIDS, according ... 2.4 percent of D.C.'s population over the age of ...
(Date:4/27/2015)... TX (PRWEB) April 27, 2015 Guided ... the field of patient experience and its collaboration with ... research, The Beryl Institute identifies eight essential actions ... , The Beryl Institute believes organizations and systems committed ... Identify and support accountable leadership with committed ...
Breaking Medicine News(10 mins):Health News:Science on Tap at the Science Museum of Virginia 2Health News:UC Davis Makes Breakthrough in Understanding Canavan Disease 2Health News:UC Davis Makes Breakthrough in Understanding Canavan Disease 3Health News:UC Davis Makes Breakthrough in Understanding Canavan Disease 4Health News:D.C. Center for AIDS Research Established with New Grant from NIH 2Health News:D.C. Center for AIDS Research Established with New Grant from NIH 3Health News:Guiding Principles for Patient Experience Excellence Identified by The Beryl Institute 2
... Maureen Salamon HealthDay Reporter , MONDAY, May ... heart attack are at increased risk of suffering another ... certain types of prescription and over-the-counter painkillers, including ... Danish researchers analyzed nationwide records of almost 84,000 ...
... MAA study by scientists at Schepens Eye Research Institute shows ... of glasses used to magnify traffic signs and lights may ... second eye. The study results, which will be published ... the first evidence that--under more realistic viewing conditions than in ...
... Reporter , MONDAY, May 9 (HealthDay News) -- A simple ... with a chronic bowel disease, a new study has found. ... at Chapel Hill, found that women with irritable bowel syndrome ... reduction in symptoms, far surpassing a nearly 12 percent reduction ...
... new, promising marker for diagnosing prostate cancer has been ... unique method developed at the Department of Immunology, Genetics ... the journal Proceedings of the National Academy of ... and fewer unnecessary operations. The PSA marker used ...
... gas appears to directly impact the source of the ... Health Sciences University researchers report. The short-acting gas ... chains that ultimately deform red blood cells and prompting ... said Dr. C. Alvin Head, Chairman of GHSU,s Department ...
... 2011 (BRONX, NY) An estimated five million ... of cases to rise dramatically as the population ages ... College of Medicine of Yeshiva University are among those ... Einstein Aging Study (EAS) , which examines both ...
Cached Medicine News:Health News:After Heart Attack, Certain Painkillers May Raise Risk for Recurrence 2Health News:After Heart Attack, Certain Painkillers May Raise Risk for Recurrence 3Health News:Single bioptic telescope for low vision driving may not obscure road view of second eye 2Health News:Single bioptic telescope for low vision driving may not obscure road view of second eye 3Health News:Mindful Meditation Might Ease Irritable Bowel Syndrome 2Health News:Mindful Meditation Might Ease Irritable Bowel Syndrome 3Health News:New marker offers hope for more reliable detection of prostate cancer 2Health News:Nitric oxide impacts source of sickle cell pain crisis 2Health News:Einstein secures $11 million to continue research on brain aging and Alzheimer's disease 2
(Date:4/27/2015)... BOULDER, Colo. , April 27, 2015 ... will report financial results for the third ... conference call to discuss those results on ... Executive Officer will lead the call.Date:Monday, May ... Code: 5249676 Webcast, including Replay and Conference ...
(Date:4/27/2015)... Inc. (NYSE: CRY ), a leading medical device ... surgery, announced today that it has received a close-out ... ("FDA") verifying that the Company has successfully implemented corrective ... received from the FDA in January 2013. ... by the FDA at CryoLife,s manufacturing facility and headquarters ...
(Date:4/27/2015)... NEW YORK , April 27, 2015   ... management solutions, will showcase advances in monitored care that ... the upcoming ATA 2015 Conference, May 2-5 ... Center. AMC Health will share information about ... monitored care to help transform and personalize healthcare delivery ...
Breaking Medicine Technology:CryoLife Announces Resolution of FDA Warning Letter 2AMC Health to Showcase Advances in Monitored Care at ATA 2015 2AMC Health to Showcase Advances in Monitored Care at ATA 2015 3AMC Health to Showcase Advances in Monitored Care at ATA 2015 4
... DIEGO, Oct. 13 RESMED INC. (NYSE: RMD ... will release its results for the first quarter of fiscal ... ResMed,s results will be issued after 1:00 p.m. Pacific Time ... to review its results, market trends, and future outlook. ...
... Care Continuum Alliance honored Kaiser Permanente,s ALL/PHASE initiative ... on Health" at The Forum 10 conference ... low-cost and generic medications and clinical interventions to reduce ... communities, including those served by safety net organizations. ...
Cached Medicine Technology:ResMed Announces Conference Call and Webcast to Discuss First Quarter 2011 Results 2Kaiser Permanente's ALL/PHASE Initiative Wins 2010 Care Continuum Alliance Quality Impact Award for Greatest Impact on Health 2Kaiser Permanente's ALL/PHASE Initiative Wins 2010 Care Continuum Alliance Quality Impact Award for Greatest Impact on Health 3
The ring maintains the bag tension avoiding the development of posterior capsule pleats. It is also established to compensate the efforts induced during the bag retraction....
... Type 14, 14A and 14C have been approved. ... to accommodate the variations in the size of ... tension rings are designed to stabilize the capsule ... large panel of U.S. ophthalmologists. For implatations ...
... is a device designed for permanent implantation ... removal surgery. It provides secondary capsular bag ... The CTR is a uniplanar, 270-degree, semi-circle ... absorbing polymethylmethacrylate (PMMA) with one manipulation eyelet ...
Stainless steel cartilage scissors....
Medicine Products: